Adma Biologics | ADMA - 영업 이익





영업 이익 변화 날짜
Adma Biologics USD 62.75M 11.74M 2025-12
Alnylam Pharmaceuticals USD 29.4M 59.36M 2025-12
BioCryst Pharmaceuticals USD 260.38M 230.79M 2025-12
Minerva Neurosciences USD -21.85M 17.48M 2024-12
Novavax USD 20.94M 100.32M 2025-12
Omeros USD -35.41M 23.75M 2024-09
Takeda JPY 168.82B 479.89B 2025-12